Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 17:56 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Not applicableRecruitingINTERVENTIONAL

Effectiveness of Pelvic Floor Muscle Rehabilitation Combined With Desmopressin in Children With Primary Monosymptomatic Nocturnal Enuresis

ClinicalTrials.gov · NCT06883851 · Registry updated: 2025-03-19

Condition / research focus: Primary Nocturnal Enuresis; Nocturnal Enuresis in Children
Sponsor: Bahçeşehir University
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2025-03-11. Completion: 2027-08-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Structured pelvic floor rehabilitation (other)

Where the study takes place — 2 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

Private Selcuk Silay Pediatric Urology Clinic
Istanbul, Beşiktaş, Turkey (Türkiye)
Site recruitment: Recruiting
Medipol Acıbadem Region Hospital
Istanbul, Kadıkoy, Turkey (Türkiye)
Site recruitment: Not yet recruiting

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

A Study in Healthy Subjects to Assess the Safety, Tolerability, PK and PD of HTL0030310

ClinicalTrials.gov · NCT03847207 · Registry updated: 2025-02-19

Condition / research focus: Healthy
Sponsor: Nxera Pharma UK Limited
Countries with listed sites: United Kingdom
Registry dates and results: Start: 2019-01-23. Completion: 2020-03-05 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

HTL0030310 (drug)
Pasireotide (drug)
Placebo (drug)

Where the study takes place — 1 listed sites

Quotient Sciences
Nottingham, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Ginko Biloba Versus Desmopressin in Treatment of Children With Monosymptomatic Nocturnal Enuresis

ClinicalTrials.gov · NCT06772584 · Registry updated: 2025-01-13

Condition / research focus: Enuresis, Nocturnal
Sponsor: Menoufia University
Countries with listed sites: Egypt
Registry dates and results: Start: 2024-01-01. Completion: 2024-12-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin Acetate 0.2 mg Tablets (drug)
Ginkgobiloba (drug)

Where the study takes place — 1 listed sites

Menofia university
Cairo, State Or Province, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Specified Drug Use-results Survey (Long-term Use) on MINIRINMELT® OD Tablet (Nocturia)

ClinicalTrials.gov · NCT04329975 · Registry updated: 2024-12-20

Condition / research focus: Nocturia Due to Nocturnal Polyuria
Sponsor: Ferring Pharmaceuticals
Countries with listed sites: Japan
Registry dates and results: Start: 2020-05-19. Completion: 2024-09-25 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin (drug) — also listed as: MINIRINMELT

Where the study takes place — 1 listed sites

Survey Site (there may be other sites in this country)
Tokyo, Japan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Nasal Desmopressin Versus Topical Epinephrine in Endonasal Dacryocystorhinostomy

ClinicalTrials.gov · NCT05507476 · Registry updated: 2024-10-01

Condition / research focus: Anesthesia
Sponsor: Zagazig University
Countries with listed sites: Egypt
Registry dates and results: Start: 2022-09-01. Completion: 2023-06-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin Acetate Nasal, 10 μg/0.1 ml per spray (drug) — also listed as: Minirin 10 μg/0.1 ml per spray
Epinephrine topical 1:100,000 Nasal Packs (drug) — also listed as: Adrenaline 1 mg / 1ml

Where the study takes place — 1 listed sites

Zagazig university hospital
Zagazig, Al-Sharkia, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Intravenous Tranexamic Acid and Intramyometrial Desmopressin Effect on Blood Loss During Laparoscopic Myomectomy.

ClinicalTrials.gov · NCT05517590 · Registry updated: 2024-05-24

Condition / research focus: Leiomyoma, Uterine; Intraoperative Blood Loss
Sponsor: Acibadem University
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2022-09-01. Completion: 2024-04-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tranexamic acid (drug) — also listed as: Group I
Saline (drug) — also listed as: Group II

Where the study takes place — 1 listed sites

Acibadem Maslak Hospital
Istanbul, Sariyer, Turkey (Türkiye)
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4TerminatedINTERVENTIONAL

Desmopressin for Bedwetting in Children With SCD

ClinicalTrials.gov · NCT04420585 · Registry updated: 2024-05-07

Condition / research focus: Nocturnal Enuresis; Anemia, Sickle Cell
Sponsor: Montefiore Medical Center
Countries with listed sites: United States
Registry dates and results: Start: 2020-07-07. Completion: 2023-06-12 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin (drug) — also listed as: DDAVP

Where the study takes place — 1 listed sites

Children's Hospital at Montefiore
The Bronx, New York, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Desmopressin Monotherapy for Monosymptomatic Nocturnal Enuresis

ClinicalTrials.gov · NCT06285006 · Registry updated: 2024-04-23

Condition / research focus: Nocturnal Enuresis
Sponsor: Al-Azhar University
Countries with listed sites: Egypt
Registry dates and results: Start: 2024-02-23. Completion: 2024-05-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin (drug)

Where the study takes place — 1 listed sites

Alazhar university
Asyut, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

A SAD/MAD Study of Safety, Tolerability and Pharmacologic Activity of BT200 in Normal Volunteers

ClinicalTrials.gov · NCT04103034 · Registry updated: 2024-03-18

Condition / research focus: Cerebrovascular Stroke; Large-Artery Atherosclerosis (Embolus/Thrombosis); Intracranial Arteriosclerosis
Sponsor: Band Therapeutics
Countries with listed sites: Austria
Registry dates and results: Start: 2019-10-07. Completion: 2020-09-14 (may be estimated). Results are posted in this registry.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

BT200 (drug)
Desmopressin (drug) — also listed as: MINIRIN® Injection
Placebo (drug)

Where the study takes place — 1 listed sites

Medical University of Vienna
Vienna, Austria
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Analysis of the Clinical Efficacy of Intravenous Application of Hemostatic Drugs in Improving the Clarity of Vision Under Endoscope, Perioperative Bleeding Volume and Anti-inflammatory Effect of Spinal Endoscopic Lumbar Fusion

ClinicalTrials.gov · NCT06255366 · Registry updated: 2024-03-15

Condition / research focus: Lumbar Spondylolisthesis; Arthrosis; Spine
Sponsor: Chengdu University of Traditional Chinese Medicine
Countries with listed sites: No country reported
Registry dates and results: Start: 2024-03-28. Completion: 2025-06-29 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Caroxime sodium sulfonate (drug)
Desmopressin (drug)
0.9% Sodium Chloride Injection (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Selective Serotonin Reuptake Inhibitors, Fluoxetine Versus the Standard Oral Desmopressin for Management of Mono-symptomatic Nocturnal Enuresis.

ClinicalTrials.gov · NCT06185361 · Registry updated: 2023-12-29

Condition / research focus: Nocturnal Enuresis; Enuresis; Enuresis, Nocturnal
Sponsor: Fayoum University Hospital
Countries with listed sites: Egypt
Registry dates and results: Start: 2022-12-01. Completion: 2024-03-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Fluoxetine 20 MG (drug)
Desmopressin (drug)

Where the study takes place — 1 listed sites

Faculty of medicine, Fayoum University
Al Fayyum, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Genetic Factors of the Desmopressin Response in Carriers of Hemophilia A

ClinicalTrials.gov · NCT06020456 · Registry updated: 2023-08-31

Condition / research focus: Carrier of Hemophilia A; Desmopressin; Factor VIII Deficiency
Sponsor: Groupe Maladies hémorragiques de Bretagne
Countries with listed sites: France
Registry dates and results: Start: 2022-01-01. Completion: 2023-04-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin (drug)

Where the study takes place — 12 listed sites

University hospital of Bordeaux
Bordeaux, France
Site recruitment: Not reported
University hospital of Brest
Brest, France
Site recruitment: Not reported
Hospices civils de Lyon
Bron, France
Site recruitment: Not reported
University hospital of Dijon
Dijon, France
Site recruitment: Not reported
University hospital of Bicêtre
Le Kremlin-Bicêtre, France
Site recruitment: Not reported
University hospital of Lille
Lille, France
Site recruitment: Not reported
Assistance publique hôpitaux de Marseille
Marseille, France
Site recruitment: Not reported
University hospital of Montpellier
Montpellier, France
Site recruitment: Not reported
University hospital of Nancy
Nancy, France
Site recruitment: Not reported
University hospital of Nantes
Nantes, France
Site recruitment: Not reported
University hospital of Rennes
Rennes, France
Site recruitment: Not reported
University hospital of Saint Etienne
Saint-Etienne, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Effect of Laser Acupuncture for Treating Monosymptomatic Nocturnal Enuresis in Adolescent Females

ClinicalTrials.gov · NCT05399173 · Registry updated: 2023-08-30

Condition / research focus: Non-Specific Urethritis
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2022-06-02. Completion: 2023-09-08 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

infrared (gallium aluminum arsenide laser) (device)
medical treatment(desmopressin acetate) (drug)

Where the study takes place — 1 listed sites

Faculty of physical therapy
Giza, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 2TerminatedINTERVENTIONAL

DDAVP in the Reduction of Post-operative Ecchymosis in Rhinoplasty

ClinicalTrials.gov · NCT01982760 · Registry updated: 2023-08-16

Condition / research focus: Postoperative Ecchymosis
Sponsor: University Hospitals Cleveland Medical Center
Countries with listed sites: United States
Registry dates and results: Start: 2013-12. Completion: 2015-06-25 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

DDAVP (drug) — also listed as: Desmopressin

Where the study takes place — 1 listed sites

Lyndhurst Surgery Center
Lyndhurst, Ohio, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Mirabegron 25 mg for Treatment of Primary Nocturnal Enuresis

ClinicalTrials.gov · NCT05617664 · Registry updated: 2023-08-03

Condition / research focus: Nocturnal Enuresis
Sponsor: Benha University
Countries with listed sites: Egypt
Registry dates and results: Start: 2022-11-23. Completion: 2023-10 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

desmopressin 120 mcg oral tablets (drug)
Mirabegron 25 MG Oral Tablet, Extended Release (drug)
behavioral therapy alone (behavioral)

Where the study takes place — 1 listed sites

Benha University Hospitals
Banhā, Qaliopia, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

The Effect of Selecting Treatment With Desmopressin or Alarm to Children With Enuresis Based on Home Recordings.

ClinicalTrials.gov · NCT03389412 · Registry updated: 2023-08-02

Condition / research focus: Enuresis, Nocturnal
Sponsor: University of Aarhus
Countries with listed sites: Belgium · China · Denmark · Poland
Registry dates and results: Start: 2017-10-01. Completion: 2023-01-03 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin (drug) — also listed as: Minirin, melt
Conditional alarm (device)

Where the study takes place — 6 listed sites

Algemeen Ziekenhuis Sint-Jan Brugge
Bruges, Belgium
Site recruitment: Not reported
Ghent University Hospital
Ghent, Belgium
Site recruitment: Not reported
First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
Site recruitment: Not reported
Aalborg University Hospital
Aalborg, Jylland, Denmark
Site recruitment: Not reported
Aarhus University Hospital
Aarhus, Jylland, Denmark
Site recruitment: Not reported
University Clinical Centre in Gdańsk
Gdansk, Poland
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Adding Desmopressin to Tamsulosin for Treatment of BPH

ClinicalTrials.gov · NCT05945420 · Registry updated: 2023-07-14

Condition / research focus: Nocturnal Polyurea in Patients With BPH
Sponsor: Mansoura University
Countries with listed sites: Egypt
Registry dates and results: Start: 2023-07-20. Completion: 2024-02-10 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin Acetate (drug)
Placebo (drug)

Where the study takes place — 1 listed sites

Urology and nephrology center
Al Mansurah, Outside U.S./Canada, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Desmopressin Melt: Impact on Sleep and Daytime Functioning

ClinicalTrials.gov · NCT01645475 · Registry updated: 2022-12-15

Condition / research focus: Monosymptomatic Nocturnal Enuresis
Sponsor: University Hospital, Ghent
Countries with listed sites: Belgium
Registry dates and results: Start: 2011-04. Completion: 2012-08 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin lyophilisate (Melt) (drug)

Where the study takes place — 1 listed sites

Ghent University Hospital
Ghent, Belgium
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Desmopressin Melt Therapy in Nocturnal Polyuria Patients: Pharmacodynamic Study

ClinicalTrials.gov · NCT01439997 · Registry updated: 2022-12-15

Condition / research focus: Nocturia
Sponsor: University Hospital, Ghent
Countries with listed sites: Belgium
Registry dates and results: Start: 2012-03-26. Completion: 2015-02-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin (drug) — also listed as: Minirin Melt 60 µg

Where the study takes place — 1 listed sites

University Hospital Ghent
Ghent, Belgium
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableUnknownOBSERVATIONAL

Genetic Influence of Genetic Factors Influencing the Desmopressin's Efficacy in Mild/Moderate Hemophilia A

ClinicalTrials.gov · NCT05628558 · Registry updated: 2022-11-28

Condition / research focus: Hemophilia A, Mild; Desmopressin; Factor VIII
Sponsor: Groupe Maladies hémorragiques de Bretagne
Countries with listed sites: France
Registry dates and results: Start: 2020-07-01. Completion: 2023-04-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin (drug) — also listed as: DDAVP

Where the study takes place — 1 listed sites

University hospital of Rennes
Rennes, Brittany Region, France
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Asia

Middle East

Europe

Oceania

Australia / New Zealand — ANZCTR ↗

Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 17:56 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Not applicableRecruitingINTERVENTIONAL

Effectiveness of Pelvic Floor Muscle Rehabilitation Combined With Desmopressin in Children With Primary Monosymptomatic Nocturnal Enuresis

ClinicalTrials.gov · NCT06883851 · Registry updated: 2025-03-19

Condition / research focus: Primary Nocturnal Enuresis; Nocturnal Enuresis in Children
Sponsor: Bahçeşehir University
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2025-03-11. Completion: 2027-08-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Structured pelvic floor rehabilitation (other)

Where the study takes place — 2 listed sites

Private Selcuk Silay Pediatric Urology Clinic
Istanbul, Beşiktaş, Turkey (Türkiye)
Site recruitment: Recruiting
Medipol Acıbadem Region Hospital
Istanbul, Kadıkoy, Turkey (Türkiye)
Site recruitment: Not yet recruiting

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

A Study in Healthy Subjects to Assess the Safety, Tolerability, PK and PD of HTL0030310

ClinicalTrials.gov · NCT03847207 · Registry updated: 2025-02-19

Condition / research focus: Healthy
Sponsor: Nxera Pharma UK Limited
Countries with listed sites: United Kingdom
Registry dates and results: Start: 2019-01-23. Completion: 2020-03-05 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

HTL0030310 (drug)
Pasireotide (drug)
Placebo (drug)

Where the study takes place — 1 listed sites

Quotient Sciences
Nottingham, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Ginko Biloba Versus Desmopressin in Treatment of Children With Monosymptomatic Nocturnal Enuresis

ClinicalTrials.gov · NCT06772584 · Registry updated: 2025-01-13

Condition / research focus: Enuresis, Nocturnal
Sponsor: Menoufia University
Countries with listed sites: Egypt
Registry dates and results: Start: 2024-01-01. Completion: 2024-12-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin Acetate 0.2 mg Tablets (drug)
Ginkgobiloba (drug)

Where the study takes place — 1 listed sites

Menofia university
Cairo, State Or Province, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Specified Drug Use-results Survey (Long-term Use) on MINIRINMELT® OD Tablet (Nocturia)

ClinicalTrials.gov · NCT04329975 · Registry updated: 2024-12-20

Condition / research focus: Nocturia Due to Nocturnal Polyuria
Sponsor: Ferring Pharmaceuticals
Countries with listed sites: Japan
Registry dates and results: Start: 2020-05-19. Completion: 2024-09-25 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin (drug) — also listed as: MINIRINMELT

Where the study takes place — 1 listed sites

Survey Site (there may be other sites in this country)
Tokyo, Japan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Nasal Desmopressin Versus Topical Epinephrine in Endonasal Dacryocystorhinostomy

ClinicalTrials.gov · NCT05507476 · Registry updated: 2024-10-01

Condition / research focus: Anesthesia
Sponsor: Zagazig University
Countries with listed sites: Egypt
Registry dates and results: Start: 2022-09-01. Completion: 2023-06-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin Acetate Nasal, 10 μg/0.1 ml per spray (drug) — also listed as: Minirin 10 μg/0.1 ml per spray
Epinephrine topical 1:100,000 Nasal Packs (drug) — also listed as: Adrenaline 1 mg / 1ml

Where the study takes place — 1 listed sites

Zagazig university hospital
Zagazig, Al-Sharkia, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Intravenous Tranexamic Acid and Intramyometrial Desmopressin Effect on Blood Loss During Laparoscopic Myomectomy.

ClinicalTrials.gov · NCT05517590 · Registry updated: 2024-05-24

Condition / research focus: Leiomyoma, Uterine; Intraoperative Blood Loss
Sponsor: Acibadem University
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2022-09-01. Completion: 2024-04-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tranexamic acid (drug) — also listed as: Group I
Saline (drug) — also listed as: Group II

Where the study takes place — 1 listed sites

Acibadem Maslak Hospital
Istanbul, Sariyer, Turkey (Türkiye)
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4TerminatedINTERVENTIONAL

Desmopressin for Bedwetting in Children With SCD

ClinicalTrials.gov · NCT04420585 · Registry updated: 2024-05-07

Condition / research focus: Nocturnal Enuresis; Anemia, Sickle Cell
Sponsor: Montefiore Medical Center
Countries with listed sites: United States
Registry dates and results: Start: 2020-07-07. Completion: 2023-06-12 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin (drug) — also listed as: DDAVP

Where the study takes place — 1 listed sites

Children's Hospital at Montefiore
The Bronx, New York, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Desmopressin Monotherapy for Monosymptomatic Nocturnal Enuresis

ClinicalTrials.gov · NCT06285006 · Registry updated: 2024-04-23

Condition / research focus: Nocturnal Enuresis
Sponsor: Al-Azhar University
Countries with listed sites: Egypt
Registry dates and results: Start: 2024-02-23. Completion: 2024-05-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin (drug)

Where the study takes place — 1 listed sites

Alazhar university
Asyut, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

A SAD/MAD Study of Safety, Tolerability and Pharmacologic Activity of BT200 in Normal Volunteers

ClinicalTrials.gov · NCT04103034 · Registry updated: 2024-03-18

Condition / research focus: Cerebrovascular Stroke; Large-Artery Atherosclerosis (Embolus/Thrombosis); Intracranial Arteriosclerosis
Sponsor: Band Therapeutics
Countries with listed sites: Austria
Registry dates and results: Start: 2019-10-07. Completion: 2020-09-14 (may be estimated). Results are posted in this registry.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

BT200 (drug)
Desmopressin (drug) — also listed as: MINIRIN® Injection
Placebo (drug)

Where the study takes place — 1 listed sites

Medical University of Vienna
Vienna, Austria
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Analysis of the Clinical Efficacy of Intravenous Application of Hemostatic Drugs in Improving the Clarity of Vision Under Endoscope, Perioperative Bleeding Volume and Anti-inflammatory Effect of Spinal Endoscopic Lumbar Fusion

ClinicalTrials.gov · NCT06255366 · Registry updated: 2024-03-15

Condition / research focus: Lumbar Spondylolisthesis; Arthrosis; Spine
Sponsor: Chengdu University of Traditional Chinese Medicine
Countries with listed sites: No country reported
Registry dates and results: Start: 2024-03-28. Completion: 2025-06-29 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Caroxime sodium sulfonate (drug)
Desmopressin (drug)
0.9% Sodium Chloride Injection (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Selective Serotonin Reuptake Inhibitors, Fluoxetine Versus the Standard Oral Desmopressin for Management of Mono-symptomatic Nocturnal Enuresis.

ClinicalTrials.gov · NCT06185361 · Registry updated: 2023-12-29

Condition / research focus: Nocturnal Enuresis; Enuresis; Enuresis, Nocturnal
Sponsor: Fayoum University Hospital
Countries with listed sites: Egypt
Registry dates and results: Start: 2022-12-01. Completion: 2024-03-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Fluoxetine 20 MG (drug)
Desmopressin (drug)

Where the study takes place — 1 listed sites

Faculty of medicine, Fayoum University
Al Fayyum, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Genetic Factors of the Desmopressin Response in Carriers of Hemophilia A

ClinicalTrials.gov · NCT06020456 · Registry updated: 2023-08-31

Condition / research focus: Carrier of Hemophilia A; Desmopressin; Factor VIII Deficiency
Sponsor: Groupe Maladies hémorragiques de Bretagne
Countries with listed sites: France
Registry dates and results: Start: 2022-01-01. Completion: 2023-04-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin (drug)

Where the study takes place — 12 listed sites

University hospital of Bordeaux
Bordeaux, France
Site recruitment: Not reported
University hospital of Brest
Brest, France
Site recruitment: Not reported
Hospices civils de Lyon
Bron, France
Site recruitment: Not reported
University hospital of Dijon
Dijon, France
Site recruitment: Not reported
University hospital of Bicêtre
Le Kremlin-Bicêtre, France
Site recruitment: Not reported
University hospital of Lille
Lille, France
Site recruitment: Not reported
Assistance publique hôpitaux de Marseille
Marseille, France
Site recruitment: Not reported
University hospital of Montpellier
Montpellier, France
Site recruitment: Not reported
University hospital of Nancy
Nancy, France
Site recruitment: Not reported
University hospital of Nantes
Nantes, France
Site recruitment: Not reported
University hospital of Rennes
Rennes, France
Site recruitment: Not reported
University hospital of Saint Etienne
Saint-Etienne, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Effect of Laser Acupuncture for Treating Monosymptomatic Nocturnal Enuresis in Adolescent Females

ClinicalTrials.gov · NCT05399173 · Registry updated: 2023-08-30

Condition / research focus: Non-Specific Urethritis
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2022-06-02. Completion: 2023-09-08 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

infrared (gallium aluminum arsenide laser) (device)
medical treatment(desmopressin acetate) (drug)

Where the study takes place — 1 listed sites

Faculty of physical therapy
Giza, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 2TerminatedINTERVENTIONAL

DDAVP in the Reduction of Post-operative Ecchymosis in Rhinoplasty

ClinicalTrials.gov · NCT01982760 · Registry updated: 2023-08-16

Condition / research focus: Postoperative Ecchymosis
Sponsor: University Hospitals Cleveland Medical Center
Countries with listed sites: United States
Registry dates and results: Start: 2013-12. Completion: 2015-06-25 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

DDAVP (drug) — also listed as: Desmopressin

Where the study takes place — 1 listed sites

Lyndhurst Surgery Center
Lyndhurst, Ohio, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Mirabegron 25 mg for Treatment of Primary Nocturnal Enuresis

ClinicalTrials.gov · NCT05617664 · Registry updated: 2023-08-03

Condition / research focus: Nocturnal Enuresis
Sponsor: Benha University
Countries with listed sites: Egypt
Registry dates and results: Start: 2022-11-23. Completion: 2023-10 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

desmopressin 120 mcg oral tablets (drug)
Mirabegron 25 MG Oral Tablet, Extended Release (drug)
behavioral therapy alone (behavioral)

Where the study takes place — 1 listed sites

Benha University Hospitals
Banhā, Qaliopia, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

The Effect of Selecting Treatment With Desmopressin or Alarm to Children With Enuresis Based on Home Recordings.

ClinicalTrials.gov · NCT03389412 · Registry updated: 2023-08-02

Condition / research focus: Enuresis, Nocturnal
Sponsor: University of Aarhus
Countries with listed sites: Belgium · China · Denmark · Poland
Registry dates and results: Start: 2017-10-01. Completion: 2023-01-03 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin (drug) — also listed as: Minirin, melt
Conditional alarm (device)

Where the study takes place — 6 listed sites

Algemeen Ziekenhuis Sint-Jan Brugge
Bruges, Belgium
Site recruitment: Not reported
Ghent University Hospital
Ghent, Belgium
Site recruitment: Not reported
First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
Site recruitment: Not reported
Aalborg University Hospital
Aalborg, Jylland, Denmark
Site recruitment: Not reported
Aarhus University Hospital
Aarhus, Jylland, Denmark
Site recruitment: Not reported
University Clinical Centre in Gdańsk
Gdansk, Poland
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Adding Desmopressin to Tamsulosin for Treatment of BPH

ClinicalTrials.gov · NCT05945420 · Registry updated: 2023-07-14

Condition / research focus: Nocturnal Polyurea in Patients With BPH
Sponsor: Mansoura University
Countries with listed sites: Egypt
Registry dates and results: Start: 2023-07-20. Completion: 2024-02-10 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin Acetate (drug)
Placebo (drug)

Where the study takes place — 1 listed sites

Urology and nephrology center
Al Mansurah, Outside U.S./Canada, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Desmopressin Melt: Impact on Sleep and Daytime Functioning

ClinicalTrials.gov · NCT01645475 · Registry updated: 2022-12-15

Condition / research focus: Monosymptomatic Nocturnal Enuresis
Sponsor: University Hospital, Ghent
Countries with listed sites: Belgium
Registry dates and results: Start: 2011-04. Completion: 2012-08 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin lyophilisate (Melt) (drug)

Where the study takes place — 1 listed sites

Ghent University Hospital
Ghent, Belgium
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Desmopressin Melt Therapy in Nocturnal Polyuria Patients: Pharmacodynamic Study

ClinicalTrials.gov · NCT01439997 · Registry updated: 2022-12-15

Condition / research focus: Nocturia
Sponsor: University Hospital, Ghent
Countries with listed sites: Belgium
Registry dates and results: Start: 2012-03-26. Completion: 2015-02-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin (drug) — also listed as: Minirin Melt 60 µg

Where the study takes place — 1 listed sites

University Hospital Ghent
Ghent, Belgium
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableUnknownOBSERVATIONAL

Genetic Influence of Genetic Factors Influencing the Desmopressin's Efficacy in Mild/Moderate Hemophilia A

ClinicalTrials.gov · NCT05628558 · Registry updated: 2022-11-28

Condition / research focus: Hemophilia A, Mild; Desmopressin; Factor VIII
Sponsor: Groupe Maladies hémorragiques de Bretagne
Countries with listed sites: France
Registry dates and results: Start: 2020-07-01. Completion: 2023-04-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin (drug) — also listed as: DDAVP

Where the study takes place — 1 listed sites

University hospital of Rennes
Rennes, Brittany Region, France
Site recruitment: Recruiting

Original record, eligibility, contacts and results →